Ikarian Capital »

Eliem Therapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Eliem Therapeutics (ELYM) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $711k 100k 7.11

More positions owned by Ikarian Capital

Sarepta Therapeutics Call Option (SRPT)
Amgen Call Option (AMGN)
Bridgebio Pharma Call Option (BBIO)
Immunovant Call Option (IMVT)
Neurocrine Biosciences Call Option (NBIX)
Pyxis Oncology Common Stock Call Option (PYXS)
Insmed Com Par $.01 Call Option (INSM)
Abeona Therapeutics Com New Call Option (ABEO)
Alnylam Pharmaceuticals Put Option (ALNY)
Aerovate Therapeutics Call Option (AVTE)
Rapt Therapeutics Call Option (RAPT)
Praxis Precision Medicines I Com New Call Option (PRAX)
Crinetics Pharmaceuticals In (CRNX)
Tarsus Pharmaceuticals (TARS)
Soleno Therapeutics (SLNO)

View all positions for Ikarian Capital

Top funds holding Eliem Therapeutics

RA Capital Management
Deep Track Capital
Samsara BioCapital
Henderson Group
Boxer Capital
Affinity Asset Advisors
Driehaus Capital Management
Geode Capital Management
BlackRock
Vanguard Group
Sphera Funds Management
Ikarian Capital
TD Asset Management
Charles Schwab Investment Management
Bank of New York Mellon

View all funds holding Eliem Therapeutics